Showing results (41-50 of 113) with videos related to
Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2007
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypesLeonia Bozzacco, Christine Trumpfheller, Frederick P Siegal, et al.Journal of Virology|June 20, 2002
Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failureGustavo H Kijak, Viviana Simon, Peter Balfe, et al.The Journal of Infectious Diseases|August 31, 2006
A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infectionFrederick M Hecht, Lei Wang, Ann Collier, et al.The Journal of Antimicrobial Chemotherapy|February 11, 2014
Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adultsMartin Markowitz, Andrew Zolopa, Kathleen Squires, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2014
A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individualsMartin Markowitz, Teresa H Evering, Donald Garmon, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2008
Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical courseNicole Prada, Brandi Davis, Patrick Jean-Pierre, et al.Journal of Virology|November 27, 2004
Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10Saurabh Mehandru, Terri Wrin, Justin Galovich, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experienceAnita Shet, Leslie Berry, Hiroshi Mohri, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2007
Long-term efficacy and safety of tipranavir boosted with ritonavir in HIV-1-infected patients failing multiple protease inhibitor regimens: 80-week data from a phase 2 studyMartin Markowitz, Leonard N Slater, Robert Schwartz, et al.Frontiers in Immunology|April 11, 2018
5' Rapid Amplification of cDNA Ends and Illumina MiSeq Reveals B Cell Receptor Features in Healthy Adults, Adults With Chronic HIV-1 Infection, Cord Blood, and Humanized MiceEric Waltari, Manxue Jia, Caroline S Jiang, et al.Pageof 12